Latif Rabia, Aldossary Deena A, Aljabari Najla A, Alowaied Saja S, Aljabari Latifah A, Albash Noor J, Alabdulhadi Aseel S, Rafique Nazish, Al-Asoom Lubna I, Salem Ayad M
Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
J Family Community Med. 2024 Jan-Mar;31(1):71-78. doi: 10.4103/jfcm.jfcm_115_23. Epub 2024 Jan 8.
Reports indicate that there are menstrual cycle disturbances following coronavirus disease 2019 (COVID-19) vaccination. The present study explored the prevalence of menstrual irregularities after COVID-19 vaccination and the association of menstrual irregularities with vaccine type, doses, immediate adverse effects, history of COVID-19 infection, and its severity.
For this cross-sectional study, 406 women of reproductive age completed an online survey about the postvaccine changes in their menstruation (cycle duration, bleeding days, and bleeding amount), COVID-19 vaccine history (doses, type of vaccine, and immediate adverse effects), history of COVID-19 infection, and its severity. Data was analyzed using SPSS; descriptive statistics were computed and Chi-square test, and binary logistic regression analysis were performed.
Of the total 406 women, 45% reported postvaccine changes in their menstrual cycle. The most common menstrual change was increased dysmenorrhea (68%), followed by an increase in the length of the cycle (52%). There was a significant association between postvaccine menstrual changes and the age, marital status, and family history of menstrual irregularities. No association was observed between postvaccine menstrual changes and COVID-19 vaccine-and COVID-19 infection-related variables. As per the best-fit model of our predictors, the odds of having postvaccine menstrual changes were 0.41 times less in "single" women (confidence interval [CI] = 0.26-0.27; < 0.001) and 1.714 times greater in women who had a "family history of menstrual irregularities" (CI = 1.092-2.690; = 0.02), respectively.
A substantial number of women complained of postvaccine menstrual changes regardless of their age, type of COVID-19 vaccine, doses, immediate adverse effects, and COVID-19 infection history/severity. Being "single" decreased the probability, whereas having a family history of menstrual irregularities increased the probability significantly of having postvaccine menstrual changes.
报告显示,2019冠状病毒病(COVID-19)疫苗接种后存在月经周期紊乱情况。本研究探讨了COVID-19疫苗接种后月经不规律的发生率,以及月经不规律与疫苗类型、剂量、即时不良反应、COVID-19感染史及其严重程度之间的关联。
在这项横断面研究中,406名育龄女性完成了一项关于疫苗接种后月经变化(周期时长、出血天数和出血量)、COVID-19疫苗接种史(剂量、疫苗类型和即时不良反应)、COVID-19感染史及其严重程度的在线调查。使用SPSS对数据进行分析;计算描述性统计量,并进行卡方检验和二元逻辑回归分析。
在406名女性中,45%报告疫苗接种后月经周期有变化。最常见的月经变化是痛经加剧(68%),其次是周期时长增加(52%)。疫苗接种后月经变化与年龄、婚姻状况以及月经不规律家族史之间存在显著关联。未观察到疫苗接种后月经变化与COVID-19疫苗及COVID-19感染相关变量之间存在关联。根据我们预测指标的最佳拟合模型,“单身”女性出现疫苗接种后月经变化的几率低0.41倍(置信区间[CI]=0.26-0.27;P<0.001),而有“月经不规律家族史”的女性出现这种情况的几率高1.714倍(CI=1.092-2.690;P=0.02)。
大量女性抱怨疫苗接种后月经有变化,无论其年龄、COVID-19疫苗类型、剂量、即时不良反应以及COVID-19感染史/严重程度如何。“单身”会降低出现这种情况的概率,而有月经不规律家族史则会显著增加疫苗接种后月经变化的概率。